Rankings
▼
Calendar
WVE
Wave Life Sciences Ltd.
$3B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$417,000
Gross Profit
-$8M
-1914.6% margin
Operating Income
-$12M
-2790.9% margin
Net Income
-$12M
-2773.4% margin
EPS (Diluted)
$-0.51
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
$390,000
Free Cash Flow
-$488,000
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$190M
Total Liabilities
$24M
Stockholders' Equity
$166M
Cash & Equivalents
$182M
← FY 2016
All Quarters
Q3 2016 →
WVE Q2 2016 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena
